Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
1. Pfizer raised its full-year profit guidance due to strong performance. 2. Q2 earnings per share were 78 cents, exceeding expectations of 58 cents. 3. Revenue reached $14.65 billion, outpacing expected $13.56 billion. 4. Cost-cutting efforts aim to save $7.7 billion by 2027. 5. Trump's tariffs and drug price cuts remain industry challenges.